(Q36455901)

English

The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

author name string

Walldius G

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Jungner I

2

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

259

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

493-519

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Fasting apoprotein B-48 level and coronary artery disease in a population without frank fasting hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoprotein B versus non-high-density lipoprotein cholesterol: and the winner is...

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Comparison of the relationships between serum apolipoprotein B and serum lipid distributions

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

The rationale for using apoA-I as a clinical marker of cardiovascular risk

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoprotein A-1 predicts coronary heart disease only at low concentrations of high-density lipoprotein cholesterol: an epidemiological study of Japanese-Americans

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Coronary artery disease in patients at low risk--apolipoprotein AI as an independent risk factor

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Role of lipid and lipoprotein profiles in risk assessment and therapy.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoprotein concentrations during treatment and recurrent coronary artery disease events

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Measurement issues related to lipoprotein heterogeneity

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Statins and stroke: evidence for cholesterol-independent effects

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoprotein A-I and B and stroke events in a community-based cohort in Taiwan: report of the Chin-Shan Community Cardiovascular Study.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu heart program

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

A community-based study of stroke incidence after myocardial infarction

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Novel metabolic risk factors for heart failure

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Lipoprotein composition and serum apolipoproteins in normoglycaemic first-degree relatives of non-insulin dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Association between insulin resistance and apolipoprotein B in normoglycemic Koreans

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Associations of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B with lifestyle factors in healthy women and men: the Stanford Five City Project

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Insulin resistance in patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Lack of association of insulin resistance and carotid intimal medial thickness in non-diabetic Asian Indian subjects

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Segment-specific effects of cardiovascular risk factors on carotid artery intima-medial thickness in women at midlife.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Determinants of endothelial dysfunction and carotid intima-media thickness in combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

High frequency of endothelial vasomotor dysfunction after acute coronary syndromes in non-culprit and angiographically normal coronary arteries: a reversible phenomenon

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Serum lipid and apolipoprotein profiles in newborns and six-year-old children: the Tallinn Young Family Study

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Lipid profile of children with a family history of coronary heart disease or hyperlipidemia: 9-year experience of an outpatient clinic for the prevention of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoproteins B and A-I as predictors of risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Small, Dense LDL and Elevated Apolipoprotein B Are the Common Characteristics for the Three Major Lipid Phenotypes of Familial Combined Hyperlipidemia

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Apolipoproteins AI and B as therapeutic targets

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

The Friedewald formula underestimates LDL cholesterol at low concentrations

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Weighing in before the fight: low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Distribution of serum apolipoproteins A-I and B and lipoprotein(a) in European elderly

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III, and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Comparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B.

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Low-density lipoprotein cholesterol in patients with stable coronary heart disease--is it time to shift our goals?

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01643.X

21 January 2018

Identifiers

10.1111/J.1365-2796.2006.01643.X

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36455901&oldid=1632260010"